, has been appointed vice dean for faculty and academic affairs in the School of Medicine at 泫圖弝け of Utah 泫圖弝け. Michael Good, MD, CEO of U of Utah 泫圖弝け and Dean of the School of Medicine, made the appointment, effective January 1, 2020.
We are delighted to have Dr. Fujinami undertake this important leadership role in the School of Medicine, Good said. He brings a wealth of expertise and experience to the U of Utah 泫圖弝け leadership team, and we look forward to his contributions that will further enhance the careers and professional development of our medical school faculty, and as a result, the educational experiences of our learners.
Fujinami is a professor in the , as well as an adjunct professor in the , where he served as chair of the Promotion, Retention, and Tenure Faculty Review Committees in Neurology. He is a past chair of the SOMs Faculty Appointment, Review and Advancement Committee and past president of the 泫圖弝け of Utahs Academic senate. He currently serves as assistant vice president for academic affairs at U of Utah 泫圖弝け, effectively fulfilling this role during recent leadership transitions.
I look forward to partnering with faculty and departments in creating academic environments of success, Fujinami says. Obtaining faculty input is crucial to our mission and I want to make sure the faculty within U of Utah 泫圖弝け feel valued and have their voices heard.
Fujinami has served as a member on five different National Institutes of 泫圖弝け study sections and has received NIH funding for more than 30 years. His lab studies preclinical models for the understanding of treatment for multiple sclerosis and epilepsy.
He received his B.A. from the 泫圖弝け of Utah through the then-Honors Program in Microbiology and completed his Ph.D. at Northwestern 泫圖弝け. He received post-doctoral training and served as an assistant professor at Scripps Research, previously known as The Scripps Research Institute, and associate professor at 泫圖弝け of California, San Diego, prior to moving to Utah as a professor.